
She is highly experienced in technology assessment, market positioning, business development, and strategic planning, and is a recognised opinion leader in the stem cell and regenerative medicine sector.
Cathy is an advisor to the national Healthtech and Medicines Knowledge Transfer Network, and the UK National Stem Cell Bank, and was the lead partner on the largest consortium funded through the UK Government’s Technology Strategy Board regenmed programme.
She is also:
-
•A life sciences advisory board member for the Worcester Polytechnic Institute (MA, USA)
-
•An advisory committee member for the charity DebRA
-
•An expert reviewer for the European Commission framework grant programmes
-
•A teacher and mentor for the University of Cambridge Master in Bioscience Enterprise programme
-
•An advisor to the Bio-Ignite summer business school (Centre for Entrepreneurial Learning)
In 2007 Cathy co-founded univerCELLmarket, the most comprehensive on-line information service for the stem cell and regenerative medicine community, and is a director of the company.
Prior to Biolatris, Cathy spent seven years as a director for the venture capital firm Avlar BioVentures and was a non-executive director to several portfolio companies. She was formerly head of drug discovery at Ribotargets Ltd and assistant director and group leader for SmithKline Beecham.
Cathy held post-doctoral fellowships at Max Delbruick Centre for Molecular Medicine (Berlin), Max Planck Institute for Molecular Genetics (Berlin), and Brown University (USA). Cathy holds a DPhil from the University of Oxford.



